BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/24/2025 6:10:09 AM | Browse: 84 | Download: 261
 |
Received |
|
2025-01-13 09:45 |
|
Peer-Review Started |
|
2025-01-13 09:45 |
|
First Decision by Editorial Office Director |
|
2025-05-12 10:00 |
|
Return for Revision |
|
2025-05-12 10:00 |
|
Revised |
|
2025-05-26 13:54 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-09-03 02:50 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-09-03 10:04 |
|
Articles in Press |
|
2025-09-03 10:04 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-10-17 01:57 |
|
Publish the Manuscript Online |
|
2025-10-24 06:10 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biochemistry & Molecular Biology |
| Manuscript Type |
Review |
| Article Title |
Oncogenic B-Raf proto-oncogene, serine/threonine kinase-mediated hedgehog signalling in the pathogenesis and targeted therapy of melanoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rafiq A Rather |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Science and Engineering Research Board |
No. PDF/2016/002730 |
|
| Corresponding Author |
Rafiq A Rather, Assistant Professor, PhD, Department of Clinical Biochemistry, Govt. Degree College Shopian, Gagren, Shopian 192303, Jammu and Kashmir, India. rafiqahmad11@gmail.com |
| Key Words |
Melanoma; Hedgehog signaling; Acetylation; Mutations; Stem cells; Glioma-associated oncogene homolog; Targeted therapy |
| Core Tip |
Oncogenic B-Raf proto-oncogene, serine/threonine kinase activates the hedgehog signaling pathway, triggering glioma-associated oncogene homolog (GLI) 1/2 transcription factors that promote melanoma cell invasion and sustain cancer stem cell self-renewal, contributing to the malignancy’s therapeutic resistance. Histone deacetylases 1/2 (HDAC1/2) suppress the acetylation of GLI1/2, facilitating their activation. Inhibiting HDAC1/2 may stabilize GLI proteins in their inactive, acetylated form, offering a novel approach to inhibit melanoma progression. Hedgehog signaling induces HDAC1/2 expression, creating a feedback loop that amplifies GLI-mediated transcription, promoting cancer stem cell renewal. Disrupting this loop could unveil new therapeutic avenues for overcoming melanoma’s resistance to treatment. |
| Publish Date |
2025-10-24 06:10 |
| Citation |
Rather RA. Oncogenic B-Raf proto-oncogene, serine/threonine kinase-mediated hedgehog signalling in the pathogenesis and targeted therapy of melanoma. World J Clin Oncol 2025; 16(10): 105117 |
| URL |
https://www.wjgnet.com/2218-4333/full/v16/i10/105117.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v16.i10.105117 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
